Filing Details
- Accession Number:
- 0001415889-24-005780
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-28 19:15:53
- Reporting Period:
- 2024-02-26
- Accepted Time:
- 2024-02-28 19:15:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1818794 | Dyne Therapeutics Inc. | DYN | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1577014 | P Jason Rhodes | C/O Dyne Therapeutics, Inc. 830 Winter St. Waltham MA 02451 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-02-26 | 136,312 | $23.59 | 6,216,250 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2024-02-26 | 64,783 | $23.98 | 6,151,467 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2024-02-26 | 20,205 | $23.59 | 1,564,932 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2024-02-26 | 9,603 | $23.98 | 1,555,329 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2024-02-26 | 11,736 | $23.59 | 909,107 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2024-02-26 | 5,580 | $23.98 | 903,527 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2024-02-27 | 272,923 | $24.38 | 5,878,544 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2024-02-27 | 25,779 | $24.68 | 5,852,765 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2024-02-27 | 40,455 | $24.38 | 1,514,874 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2024-02-27 | 3,821 | $24.68 | 1,511,053 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2024-02-27 | 23,505 | $24.38 | 880,022 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2024-02-27 | 2,216 | $24.68 | 877,806 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2024-02-28 | 152,244 | $24.83 | 5,700,521 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2024-02-28 | 2,430 | $25.25 | 5,698,091 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2024-02-28 | 22,567 | $24.83 | 1,488,486 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2024-02-28 | 360 | $25.25 | 1,488,126 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2024-02-28 | 13,109 | $24.83 | 864,697 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2024-02-28 | 210 | $25.25 | 864,487 | No | 4 | S | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
Footnotes
- This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Atlas Venture Fund XI, L.P. on January 10, 2024.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.83 to $23.82 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (9), (10), (11) and (12).
- The shares are held directly by Atlas Venture Fund XI, L.P. ("Atlas Venture Fund XI"). The general partner of Atlas Venture Fund XI is Atlas Venture Associates XI, L.P. ("AVA XI LP"). Atlas Venture Associates XI, LLC ("AVA XI LLC") is the general partner of AVA XI LP. The Reporting Person is a member of AVA XI LLC and disclaims beneficial ownership of such securities held by Atlas Venture Fund XI, except to the extent of his pecuniary interest therein, if any.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.83 to $24.04 inclusive.
- This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Atlas Venture Opportunity Fund I, L.P. on January 10, 2024.
- The shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("AVOF I"). The general partner of AVOF I is Atlas Venture Associates Opportunity I, L.P. ("AVAO I LP"). Atlas Venture Associates Opportunity I, LLC ("AVAO I LLC") is the general partner of AVAO I LP. The reporting person is a member of AVAO I LLC and disclaims beneficial ownership of such securities held by AVOF I, except to the extent of his pecuniary interest therein, if any.
- This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Atlas Venture Opportunity Fund II, L.P. on January 10, 2024.
- The shares are owned directly by Atlas Venture Opportunity Fund II, L.P. ("AVOF II"). Atlas Venture Associates Opportunity II, LP ("AVAO II LP") is the general partner of AVOF II. Atlas Venture Associates Opportunity II, LLC ("AVAO II LLC") is the general partner of AVAO II LP. The Reporting Person is a member of AVAO II LLC and disclaims Section 16 beneficial ownership of such securities held by AVOF II, except to the extent of his pecuniary interest therein, if any.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.62 to $24.615 inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.62 to $24.76 inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.25 to $25.235 inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.25 to $25.255 inclusive.